{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:55:24Z","timestamp":1777964124314,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sleep Breath"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11325-024-03163-5","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T06:30:16Z","timestamp":1732689016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of sodium oxybate treatment in adults with narcolepsy and cataplexy: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7065-381X","authenticated-orcid":false,"given":"Ahmed Mostafa","family":"Amin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehya","family":"Khlidj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Esawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashad G.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"3163_CR1","doi-asserted-by":"publisher","first-page":"16100","DOI":"10.1038\/nrdp.2016.100","volume":"3","author":"BR Kornum","year":"2017","unstructured":"Kornum BR et al (2017) Narcolepsy. Nat Rev Dis Primers 3:16100. https:\/\/doi.org\/10.1038\/nrdp.2016.100","journal-title":"Nat Rev Dis Primers"},{"issue":"9560","key":"3163_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","volume":"369","author":"Y Dauvilliers","year":"2007","unstructured":"Dauvilliers Y, Arnulf I, Mignot E (2007) Narcolepsy with cataplexy. Lancet 369(9560):499\u2013511. https:\/\/doi.org\/10.1016\/S0140-6736(07)60237-2","journal-title":"Lancet"},{"issue":"9","key":"3163_CR3","first-page":"1352","volume":"27","author":"AS BaHammam","year":"2006","unstructured":"BaHammam AS, Alenezi AM (2006) Narcolepsy in Saudi Arabia. Demographic and clinical perspective of an under-recognized disorder. Saudi Med J 27(9):1352\u20131357","journal-title":"Saudi Med J"},{"issue":"2","key":"3163_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/sleep\/25.2.197","volume":"25","author":"MH Silber","year":"2002","unstructured":"Silber MH, Krahn LE, Olson EJ, Pankratz VS (2002) The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 25(2):197\u2013202. https:\/\/doi.org\/10.1093\/sleep\/25.2.197","journal-title":"Sleep"},{"key":"3163_CR5","unstructured":"\u201cNarcolepsy Public Meeting: September 24, 2013 Report Date: June 2014.\u201d"},{"issue":"4","key":"3163_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s0092-8674(00)81969-8","volume":"98","author":"JM Siegel","year":"1999","unstructured":"Siegel JM (1999) Narcolepsy: a key role for hypocretins (orexins). Cell 98(4):409\u2013412. https:\/\/doi.org\/10.1016\/s0092-8674(00)81969-8","journal-title":"Cell"},{"issue":"4","key":"3163_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s0092-8674(00)81973-x","volume":"98","author":"RM Chemelli","year":"1999","unstructured":"Chemelli RM et al (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98(4):437\u2013451. https:\/\/doi.org\/10.1016\/s0092-8674(00)81973-x","journal-title":"Cell"},{"issue":"3","key":"3163_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/s0092-8674(00)81965-0","volume":"98","author":"L Lin","year":"1999","unstructured":"Lin L et al (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98(3):365\u2013376. https:\/\/doi.org\/10.1016\/s0092-8674(00)81965-0","journal-title":"Cell"},{"issue":"9197","key":"3163_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","volume":"355","author":"S Nishino","year":"2000","unstructured":"Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355(9197):39\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(99)05582-8","journal-title":"Lancet"},{"issue":"3","key":"3163_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/s0896-6273(00)00058-1","volume":"27","author":"TC Thannickal","year":"2000","unstructured":"Thannickal TC et al (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27(3):469\u2013474. https:\/\/doi.org\/10.1016\/s0896-6273(00)00058-1","journal-title":"Neuron"},{"issue":"27","key":"3163_CR11","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMra1500587","volume":"373","author":"TE Scammell","year":"2015","unstructured":"Scammell TE (2015) Narcolepsy. N Engl J Med 373(27):2654\u20132662. https:\/\/doi.org\/10.1056\/NEJMra1500587","journal-title":"N Engl J Med"},{"issue":"1","key":"3163_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40263-019-00689-1","volume":"34","author":"MJ Thorpy","year":"2020","unstructured":"Thorpy MJ (2020) Recently approved and upcoming treatments for narcolepsy. CNS Drugs 34(1):9\u201327. https:\/\/doi.org\/10.1007\/s40263-019-00689-1","journal-title":"CNS Drugs"},{"issue":"1","key":"3163_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.sleep.2014.10.002","volume":"16","author":"MJ Thorpy","year":"2015","unstructured":"Thorpy MJ, Dauvilliers Y (2015) Clinical and practical considerations in the pharmacologic management of narcolepsy. Sleep Med 16(1):9\u201318. https:\/\/doi.org\/10.1016\/j.sleep.2014.10.002","journal-title":"Sleep Med"},{"issue":"12","key":"3163_CR14","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","volume":"30","author":"TI Morgenthaler","year":"2007","unstructured":"Morgenthaler TI et al (2007) Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 30(12):1705\u20131711. https:\/\/doi.org\/10.1093\/sleep\/30.12.1705","journal-title":"Sleep"},{"issue":"5","key":"3163_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40263-016-0337-4","volume":"30","author":"L Barateau","year":"2016","unstructured":"Barateau L, Lopez R, Dauvilliers Y (2016) Treatment options for narcolepsy. CNS Drugs 30(5):369\u2013379. https:\/\/doi.org\/10.1007\/s40263-016-0337-4","journal-title":"CNS Drugs"},{"key":"3163_CR16","unstructured":"Dominguez A, Soca Gallego L, Parmar M (2024) \u201cSodium Oxybate,\u201d in StatPearls, Treasure Island (FL): StatPearls Publishing"},{"issue":"4","key":"3163_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/jsr.12468","volume":"26","author":"T Roth","year":"2017","unstructured":"Roth T, Dauvilliers Y, Guinta D, Alvarez-Horine S, Dynin E, Black J (2017) Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy. J Sleep Res 26(4):407\u2013414. https:\/\/doi.org\/10.1111\/jsr.12468","journal-title":"J Sleep Res"},{"key":"3163_CR18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"M Page","year":"2021","unstructured":"Page M et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"1","key":"3163_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst. Rev 5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst. Rev"},{"key":"3163_CR20","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"1","key":"3163_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med. Res. Methodol 14(1):135. https:\/\/doi.org\/10.1186\/1471-2288-14-135","journal-title":"BMC Med. Res. Methodol"},{"issue":"7109","key":"3163_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"issue":"7","key":"3163_CR23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","volume":"29","author":"J Black","year":"2006","unstructured":"Black J, Houghton WC (2006) Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep 29(7):939\u2013946. https:\/\/doi.org\/10.1093\/sleep\/29.7.939","journal-title":"Sleep"},{"key":"3163_CR24","doi-asserted-by":"publisher","unstructured":"Kushida CA et al (2022 Jun) \u201cOnce-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.\u201d Sleep 45(6). https:\/\/doi.org\/10.1093\/sleep\/zsab200","DOI":"10.1093\/sleep\/zsab200"},{"key":"3163_CR25","unstructured":"(2002 Feb) \u201cA randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.\u201d Sleep 25(1):42\u201349"},{"key":"3163_CR26","doi-asserted-by":"publisher","unstructured":"U.S. Xyrem Multicenter Study Group9 (2004 Mar) \u201cSodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.\u201d Sleep Med 5(2):119\u2013123. https:\/\/doi.org\/10.1016\/j.sleep.2003.11.002","DOI":"10.1016\/j.sleep.2003.11.002"},{"key":"3163_CR27","doi-asserted-by":"publisher","unstructured":"Xyrem International Study Group (2005 Sep) \u201cFurther evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.\u201d Sleep Med 6(5):415\u2013421. https:\/\/doi.org\/10.1016\/j.sleep.2005.03.010","DOI":"10.1016\/j.sleep.2005.03.010"},{"issue":"12","key":"3163_CR28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2165\/00023210-200620120-00004","volume":"20","author":"D Pardi","year":"2006","unstructured":"Pardi D, Black J (2006) gamma-Hydroxybutyrate\/sodium oxybate: neurobiology, and impact on sleep and wakefulness. CNS Drugs 20(12):993\u20131018. https:\/\/doi.org\/10.2165\/00023210-200620120-00004","journal-title":"CNS Drugs"},{"key":"3163_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1054-3589(10)58006-2","volume":"58","author":"CL Padgett","year":"2010","unstructured":"Padgett CL, Slesinger PA (2010) GABAB receptor coupling to G-proteins and ion channels. Adv Pharmacol 58:123\u2013147. https:\/\/doi.org\/10.1016\/S1054-3589(10)58006-2","journal-title":"Adv Pharmacol"},{"key":"3163_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.smrv.2018.09.006","volume":"43","author":"ST Szabo","year":"2019","unstructured":"Szabo ST, Thorpy MJ, Mayer G, Peever JH, Kilduff TS (2019) Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. Sleep Med Rev 43:23\u201336. https:\/\/doi.org\/10.1016\/j.smrv.2018.09.006","journal-title":"Sleep Med Rev"},{"issue":"10","key":"3163_CR31","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/ncpneuro0300","volume":"2","author":"JM Siegel","year":"2006","unstructured":"Siegel JM, Boehmer LN (2006) Narcolepsy and the hypocretin system\u2013where motion meets emotion. Nat Clin Pract Neurol 2(10):548\u2013556. https:\/\/doi.org\/10.1038\/ncpneuro0300","journal-title":"Nat Clin Pract Neurol"},{"key":"3163_CR32","doi-asserted-by":"publisher","unstructured":"Wu M-F, Thannickal TC, Li S, McGregor R, Lai Y-Y, Siegel JM (2023 Sep) \u201cEffects of sodium oxybate on hypocretin\/orexin and locus coeruleus neurons.\u201d Sleep 46(9). https:\/\/doi.org\/10.1093\/sleep\/zsad135","DOI":"10.1093\/sleep\/zsad135"},{"issue":"1","key":"3163_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/1756283X15618131","volume":"9","author":"P Singh","year":"2016","unstructured":"Singh P, Yoon SS, Kuo B (2016) Nausea: a review of pathophysiology and therapeutics. Therap Adv Gastroenterol 9(1):98\u2013112. https:\/\/doi.org\/10.1177\/1756283X15618131","journal-title":"Therap Adv Gastroenterol"},{"key":"3163_CR34","doi-asserted-by":"publisher","first-page":"402585","DOI":"10.1155\/2013\/402585","volume":"2013","author":"EJ Choi","year":"2013","unstructured":"Choi EJ, Yun Y, Yoo S, Kim KS, Park J-S, Choi I (2013) Autonomic conditions in tinnitus and implications for korean medicine. Evid Based Complement Alternat Med 2013:402585. https:\/\/doi.org\/10.1155\/2013\/402585","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"3163_CR35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/00016489.2016.1269197","volume":"137","author":"J Ylikoski","year":"2017","unstructured":"Ylikoski J et al (2017) Non-invasive vagus nerve stimulation reduces sympathetic preponderance in patients with tinnitus. Acta Otolaryngol 137(4):426\u2013431. https:\/\/doi.org\/10.1080\/00016489.2016.1269197","journal-title":"Acta Otolaryngol"},{"key":"3163_CR36","doi-asserted-by":"publisher","unstructured":"Bascom A, McMaster MA, Alexander RT, MacLean JE (2019 Mar) \u201cNocturnal enuresis in children is associated with differences in autonomic control.\u201d Sleep 42(3). https:\/\/doi.org\/10.1093\/sleep\/zsy239","DOI":"10.1093\/sleep\/zsy239"},{"issue":"1","key":"3163_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jpurol.2022.10.015","volume":"19","author":"M Angeli","year":"2023","unstructured":"Angeli M, Bitsori M, Rouva G, Galanakis E (2023) The role of the autonomic nervous system in nocturnal enuresis. J Pediatr Urol 19(1):6\u201318. https:\/\/doi.org\/10.1016\/j.jpurol.2022.10.015","journal-title":"J Pediatr Urol"},{"issue":"10 Pt 1","key":"3163_CR38","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/0895-7061(96)00171-9","volume":"9","author":"K Takenaka","year":"1996","unstructured":"Takenaka K et al (1996) GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats. Am J Hypertens 9(10 Pt 1):964\u2013972. https:\/\/doi.org\/10.1016\/0895-7061(96)00171-9","journal-title":"Am J Hypertens"},{"key":"3163_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1054-3589(10)58011-6","volume":"58","author":"D-P Li","year":"2010","unstructured":"Li D-P, Pan H-L (2010) Role of GABAB receptors in autonomic control of systemic blood pressure. Adv Pharmacol 58:257\u2013286. https:\/\/doi.org\/10.1016\/S1054-3589(10)58011-6","journal-title":"Adv Pharmacol"},{"issue":"2","key":"3163_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3978\/j.issn.2224-5820.2012.07.04","volume":"1","author":"HS Smith","year":"2012","unstructured":"Smith HS, Smith EJ, Smith AR (2012) Pathophysiology of nausea and vomiting in palliative medicine. Ann Palliat Med 1(2):87\u201393. https:\/\/doi.org\/10.3978\/j.issn.2224-5820.2012.07.04","journal-title":"Ann Palliat Med"},{"issue":"3","key":"3163_CR41","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1152\/jn.00243.2020","volume":"124","author":"Y Ramakrishna","year":"2020","unstructured":"Ramakrishna Y, Sadeghi SG (2020) Activation of GABAB receptors results in excitatory modulation of calyx terminals in rat semicircular canal cristae. J Neurophysiol 124(3):962\u2013972. https:\/\/doi.org\/10.1152\/jn.00243.2020","journal-title":"J Neurophysiol"},{"issue":"1","key":"3163_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/157015910790909511","volume":"8","author":"E Soto","year":"2010","unstructured":"Soto E, Vega R (2010) Neuropharmacology of vestibular system disorders. Curr Neuropharmacol 8(1):26\u201340. https:\/\/doi.org\/10.2174\/157015910790909511","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"3163_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.5664\/jcsm.2048","volume":"8","author":"MK Alshaikh","year":"2012","unstructured":"Alshaikh MK, Tricco AC, Tashkandi M, Mamdani M, Straus SE, BaHammam AS (2012) Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis. J Clin Sleep Med 8(4):451\u2013458. https:\/\/doi.org\/10.5664\/jcsm.2048","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"3163_CR44","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s13311-012-0150-9","volume":"9","author":"EJM Mignot","year":"2012","unstructured":"Mignot EJM (2012) A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics 9(4):739\u2013752. https:\/\/doi.org\/10.1007\/s13311-012-0150-9","journal-title":"Neurotherapeutics"},{"issue":"2","key":"3163_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/17460441.2022.1999226","volume":"17","author":"G Junnarkar","year":"2022","unstructured":"Junnarkar G et al (2022) Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia. Expert Opin Drug Discov 17(2):109\u2013119. https:\/\/doi.org\/10.1080\/17460441.2022.1999226","journal-title":"Expert Opin Drug Discov"}],"container-title":["Sleep and Breathing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-024-03163-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11325-024-03163-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-024-03163-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T10:16:34Z","timestamp":1743156994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11325-024-03163-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3163"],"URL":"https:\/\/doi.org\/10.1007\/s11325-024-03163-5","relation":{},"ISSN":["1520-9512","1522-1709"],"issn-type":[{"value":"1520-9512","type":"print"},{"value":"1522-1709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a systematic review and meta-analysis that did not require ethical approval, as it did not involve the direct participation of individuals who would provide informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Consent to publication is not applicable in this case since this study is not a primary research study but rather a review and analysis of existing literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"We declare that this research paper has not been published elsewhere in any other academic journal or platform.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous publication"}},{"value":"We declare that we have not used AI in writing any part of this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI in scientific writing"}},{"value":"No conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"12"}}